Trump Unveils Deal on Lower Obesity Drug Prices, Expanding Coverage Nationwide

President Donald Trump announced a deal with pharmaceutical companies Eli Lilly and Novo Nordisk to increase insurance coverage and lower costs for their obesity medications Zepbound and Wegovy. The agreement aims to provide more people access to life-saving treatments for conditions like type 2 diabetes and weight loss. Under the terms of the deal, patients will pay no more than $30 monthly out-of-pocket for these medications. This move is expected to benefit thousands of Americans struggling with obesity.